Lead series optimization Our goal was to enhance interactions of the small-molecule agonists with the GLP-1R through lowering the energy barrier to achieve the receptor-bound agonist conformation, and by adjusting polar substituents, with minimal increases in molecular weight
On paper, Inno Shred GLP-1 looks like a budget-friendly way to mimic prescription GLP-1s
July 1 is just around the corner so, hopefully, there will be more guidance coming soon.
Read BPC-157 Peptide Therapy for Tendon Repair, Shoulder Injuries, Tennis Elbow & Achilles Recovery and BPC-157 and the Brain-Gut Axis: Gut Integrity, Systemic Inflammatory Signaling, and the Science of Gastrointestinal Repair for a deeper understanding backed by science
Whats Inside
10.1038/nature03317 Nature 133 NguyenA